v3.26.3
Research and Development (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Chemomab Therapeutics Ltd [Member]    
Schedule of Research and Development

 

   Six Months ended   Three Months ended   Six Months ended   Three Months ended 
   June 30, 2026   June 30, 2026   June 30, 2025   June 30, 2026 
   USD thousands   USD thousands   USD thousands   USD thousands 
Consultants and subcontractors   1,076    644    2,572    817 
Salaries and related expenses   862    432    1,085    459 
Lease and maintenance   22    11    58    31 
Share-based compensation   79    37    22    (39)
Other expenses   28    18    43    19 
Total   2,067    1,142    3,780    1,287 

 

   Year ended   Year ended   Year ended 
   December 31,   December 31,   December 31, 
   2025   2024   2023 
   USD thousands   USD thousands   USD thousands 
Consultants and subcontractors   3,640    7,994    14,014 
Salaries and related expenses   1,848    2,715    3,362 
Lease and maintenance   79    101    137 
Share-based compensation   158    401    407 
Other expenses   108    116    461 
Total   5,833    11,327    18,381